Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ: APOP) fell 29.5 percent to $4.31. Cellect Biotechnology shares surged Thursday after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.
Latest Ratings for APOP
Date
Firm
Action
From
To
Nov 2016
Rodman & Renshaw
Initiates Coverage On
Buy
View More Analyst Ratings for APOP
View the Latest Analyst Ratings